Navjot Pabla, PhD

Navjot Pabla


College of Pharmacy

Academic Title

Asst Professor

Research Program

Translational Therapeutics

Dr. Pabla’s laboratory is focused on identifying therapeutic targets for kidney diseases. Acute kidney injury and renal cell carcinoma are the two major areas of interest. The lab’s recent work has identified several protein kinases and membrane transporters as therapeutic targets for renal disorders. They utilize high throughput screening assays and functional genomics to identify molecular targets for renal diseases, followed by validation in in vivo animal models. The overall goal of these studies is to identify new therapeutic strategies to treat acute kidney injury and renal cell carcinoma, diseases for which no effective therapies are currently available.

Education and Background

Office Location

406 BRT

460 W 12th Avenue, Columbus, OH 43210


  • OCTN1 Is a High-Affinity Carrier of Nucleoside Analogues.

    Drenberg C, Gibson AA, Pounds S, Shi L, Rhinehart D, Li L, Hu S, Du G, Nies AT, Schwab M, Pabla N, Blum W, Gruber TA, Baker SD, Sparreboom A, Drenberg CD, Gibson AA, Pounds SB, Shi L, Rhinehart DP, Li L, Hu S, Du G, Nies AT, Schwab M, Pabla N, Blum W, Gruber TA, Baker SD, Sparreboom A

    Cancer Res 77 2102-2111 04/15/2017

  • A phosphotyrosine switch regulates organic cation transporters.

    Sprowl JA, Ong SS, Gibson AA, Hu S, Du G, Lin W, Li L, Bharill S, Ness RA, Stecula A, Offer SM, Diasio RB, Nies AT, Schwab M, Cavaletti G, Schlatter E, Ciarimboli G, Schellens JH, Isacoff EY, Sali A, Chen T, Baker SD, Sparreboom A, Pabla N

    Nat Commun 7 10880 03/16/2016

  • See Full List
Back to Researcher Search

Please enter a keyword (i.e. Name, Research Interest) or choose a Research Program


Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator


Search for Clinical Trials

Find a Scientific Publication